🇺🇸 FDA
Patent

US 8524676

Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds

granted A61KA61K38/00

Quick answer

US patent 8524676 (Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds) held by Sarepta Therapeutics, Inc. expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00